NCT03448679View on ClinicalTrials.gov

Albumin, COP and Endothelial Damage in Patients With ESLD Undergoing OLT

CompletedOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

December 6, 2015

Primary Completion Date

December 6, 2016

Study Completion Date

December 6, 2016

Conditions

Transplant-Related Disorder

All Listed Sponsors

lead

Medical University of Vienna

OTHER

NCT03448679 - Albumin, COP and Endothelial Damage in Patients With ESLD Undergoing OLT | Biotech Hunter | Biotech Hunter